We are live on ! Find out more
SAM

Shell Asset Management Portfolio holdings

AUM $996M
1-Year Est. Return 26.19%
This Fund
S&P 500
This Quarter Est. Return
+8.77%
1 Year Est. Return
+26.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.16B
AUM Growth
+$160M
Cap. Flow
-$209M
Cap. Flow %
-4.06%
Top 10 Hldgs %
25.01%
Holding
1,594
New
146
Increased
658
Reduced
598
Closed
83

Top Buys

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$21.3M
2
JPM icon
JPMorgan Chase
JPM
+$14M
3
EQX icon
Equinox Gold
EQX
+$12.9M
4
ABT icon
Abbott
ABT
+$12.7M
5
META icon
Meta Platforms (Facebook)
META
+$12.2M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$19.7M
2
MSFT icon
Microsoft
MSFT
+$19.7M
3
AAPL icon
Apple
AAPL
+$16.8M
4
BAC icon
Bank of America
BAC
+$11.6M
5
MCD icon
McDonald's
MCD
+$11M

Sector Composition

Rank Sector Weight
1 Technology 23.32%
2 Financials 15.15%
3 Consumer Discretionary 14.29%
4 Healthcare 11.83%
5 Communication Services 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEN icon
1351
Lennar Class A
LEN
$19.3B
$106K ﹤0.01%
1,099
-798
-42% -$77.1K
UIS icon
1352
Unisys
UIS
$183M
$105K ﹤0.01%
4,145
ALGM icon
1353
Allegro MicroSystems
ALGM
$6.2B
$104K ﹤0.01%
+3,743
New +$97.7K
EXK
1354
Endeavour Silver
EXK
$2.85B
$104K ﹤0.01%
16,994
DFTX
1355
Definium Therapeutics
DFTX
$4.95B
$104K ﹤0.01%
+2,001
New +$105K
NCNO icon
1356
nCino
NCNO
$2.32B
$104K ﹤0.01%
+1,736
New +$109K
OCUL icon
1357
Ocular Therapeutix
OCUL
$2.24B
$103K ﹤0.01%
7,263
SII
1358
Sprott
SII
$3.27B
$103K ﹤0.01%
2,613
VCYT icon
1359
Veracyte
VCYT
$3.23B
$103K ﹤0.01%
2,582
TIGR
1360
UP Fintech Holding
TIGR
$847M
$101K ﹤0.01%
+3,500
New +$74.5K
BZUN
1361
Baozun
BZUN
$159M
$100K ﹤0.01%
2,816
-881
-24% -$31K
ACCO icon
1362
Acco Brands
ACCO
$392M
$99K ﹤0.01%
11,417
IT icon
1363
Gartner
IT
$12.4B
$99K ﹤0.01%
410
TSN icon
1364
Tyson Foods
TSN
$18.5B
$99K ﹤0.01%
1,343
-514
-28% -$39.9K
LL
1365
DELISTED
LL Flooring Holdings, Inc.
LL
$99K ﹤0.01%
4,677
JBLU icon
1366
JetBlue
JBLU
$1.61B
$98K ﹤0.01%
+5,863
New +$114K
OCGN icon
1367
Ocugen
OCGN
$337M
$97K ﹤0.01%
+12,044
New +$102K
VMRK
1368
Vivmark Residential
VMRK
$50.8B
$96K ﹤0.01%
1,243
-6,429
-84% -$486K
AHCO icon
1369
AdaptHealth
AHCO
$776M
$95K ﹤0.01%
+3,456
New +$98.6K
HWM icon
1370
Howmet Aerospace
HWM
$89.6B
$94K ﹤0.01%
2,718
VHC icon
1371
VirnetX Holding Corp
VHC
$47.5M
$94K ﹤0.01%
1,100
DBD
1372
DELISTED
Diebold Nixdorf Incorporated
DBD
$94K ﹤0.01%
7,314
PNW icon
1373
Pinnacle West Capital
PNW
$11.5B
$93K ﹤0.01%
1,136
-523
-32% -$44.2K
SA
1374
Seabridge Gold
SA
$3.16B
$93K ﹤0.01%
5,315
+100
+2% +$1.81K
SVM
1375
Silvercorp Metals
SVM
$2.52B
$93K ﹤0.01%
16,953

Similar funds

Shell Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Shell Asset Management held 1,594 positions worth $5.16B, up 3.2% from $5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Shell Asset Management withdrew a net $209M in Q2 2021, closing 83 positions and reducing 598 holdings. Its most notable exit was Axalta, an estimated $1.98M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Shell Asset Management opened a new position in Paya Holdings Inc. Class A Common Stock worth $1.99M.

  • Shell Asset Management's largest Q2 2021 buy was Paya Holdings Inc. Class A Common Stock: 180,692 shares worth $1.99M.
  • Shell Asset Management added most to Fiserv Inc in Q2 2021, an estimated $21.3M increase.
  • Shell Asset Management's biggest Q2 2021 reduction was Johnson & Johnson, cutting an estimated $19.7M.
  • Shell Asset Management fully exited Axalta in Q2 2021, selling an estimated $1.98M.
  • Shell Asset Management's ten largest holdings make up 25% of its $5.16B portfolio in Q2 2021.
  • Shell Asset Management opened 146 new positions and closed 83 in Q2 2021.
  • Shell Asset Management's portfolio value rose 3.2% quarter-over-quarter to $5.16B.

Based on Shell Asset Management's 13F filing for Q2 2021, filed 12 Aug 2021.